15q13. 3 microdeletions increase risk of idiopathic generalized epilepsy I Helbig, HC Mefford, AJ Sharp, M Guipponi, M Fichera, A Franke, ... Nature genetics 41 (2), 160-162, 2009 | 676 | 2009 |
A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add‐on therapy to carbamazepine in patients with … AP Aldenkamp, G Baker, OG Mulder, D Chadwick, P Cooper, J Doelman, ... Epilepsia 41 (9), 1167-1178, 2000 | 277 | 2000 |
Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study GJ De Haan, P Edelbroek, J Segers, M Engelsman, D Lindhout, ... Neurology 63 (3), 571-573, 2004 | 247 | 2004 |
Genome search for susceptibility loci of common idiopathic generalised epilepsies T Sander, H Schulz, K Saar, E Gennaro, MC Riggio, A Bianchi, F Zara, ... Human molecular genetics 9 (10), 1465-1472, 2000 | 216 | 2000 |
Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers PD Knoester, DM Jonker, RTM Van Der Hoeven, TAC Vermeij, ... British journal of clinical pharmacology 53 (5), 501-507, 2002 | 187 | 2002 |
Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies RJL Anney, A Avbersek, D Balding, L Baum, F Becker, SF Berkovic, ... The Lancet Neurology, 2014 | 169 | 2014 |
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16. 1, 2q22. 3 and 17q21. 32 Epicure Consortium, EMINet Consortium, M Steffens, C Leu, AK Ruppert, ... Human molecular genetics 21 (24), 5359-5372, 2012 | 153 | 2012 |
A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations GJ De Haan, P Van Der Geest, G Doelman, E Bertram, P Edelbroek Epilepsia 51 (3), 478-482, 2010 | 117 | 2010 |
Current approaches to the use of generic antiepileptic drugs G Krämer, A Biraben, M Carreno, A Guekht, GJ De Haan, J Jędrzejczak, ... Epilepsy & Behavior 11 (1), 46-52, 2007 | 109 | 2007 |
Genome-wide linkage scan of epilepsy-related photoparoxysmal electroencephalographic response: evidence for linkage on chromosomes 7q32 and 16p13 D Pinto, B Westland, GJ de Haan, G Rudolf, BM da Silva, E Hirsch, ... Human molecular genetics 14 (1), 171-178, 2005 | 103 | 2005 |
Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP T Tomson, D Battino, E Bonizzoni, JJ Craig, D Lindhout, E Perucca, ... Neurology 85 (7), 580-588, 2015 | 86 | 2015 |
Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations K Alakurtti, E Weber, R Rinne, G Theil, GJ Haan, D Lindhout, ... European Journal of Human Genetics 13 (2), 208-215, 2005 | 84 | 2005 |
Carbamazepine‐and oxcarbazepine‐induced hyponatremia in people with epilepsy B Berghuis, J van der Palen, GJ de Haan, D Lindhout, BPC Koeleman, ... Epilepsia 58 (7), 1227-1233, 2017 | 80 | 2017 |
Sudden cardiac arrest in people with epilepsy in the community: circumstances and risk factors RJ Lamberts, MT Blom, M Wassenaar, A Bardai, FS Leijten, GJ de Haan, ... Neurology 85 (3), 212-218, 2015 | 76 | 2015 |
Influence of an evacuation in February 1995 in The Netherlands on the seizure frequency in patients with epilepsy: a controlled study WAM Swinkels, M Engelsman, DGA Kasteleijn‐Nolst Trenité, MG Baal, ... Epilepsia 39 (11), 1203-1207, 1998 | 72 | 1998 |
Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy I Wegner, P Edelbroek, GJ De Haan, D Lindhout, JW Sander Epilepsia 51 (12), 2500-2502, 2010 | 58 | 2010 |
Epidemiology, pathophysiology and putative genetic basis of carbamazepine‐and oxcarbazepine‐induced hyponatremia B Berghuis, GJ de Haan, MPH van den Broek, JW Sander, D Lindhout, ... European journal of neurology 23 (9), 1393-1399, 2016 | 54 | 2016 |
Telephone‐induced seizures: a new type of reflex epilepsy R Michelucci, E Gardella, GJ De Haan, F Bisulli, A Zaniboni, G Cantalupo, ... Epilepsia 45 (3), 280-283, 2004 | 53 | 2004 |
Selection criteria for the clinical use of the newer antiepileptic drugs CLP Deckers, PD Knoester, GJ de Haan, A Keyser, WO Renier, ... CNS drugs 17, 405-421, 2003 | 53 | 2003 |
Retinal nerve fiber layer thickness in vigabatrin‐exposed patients LM Clayton, M Dévilé, T Punte, C Kallis, GJ de Haan, JW Sander, ... Annals of neurology 69 (5), 845-854, 2011 | 50 | 2011 |